PL2031063T3 - Modulatory receptorów węchowych - Google Patents
Modulatory receptorów węchowychInfo
- Publication number
- PL2031063T3 PL2031063T3 PL08013482T PL08013482T PL2031063T3 PL 2031063 T3 PL2031063 T3 PL 2031063T3 PL 08013482 T PL08013482 T PL 08013482T PL 08013482 T PL08013482 T PL 08013482T PL 2031063 T3 PL2031063 T3 PL 2031063T3
- Authority
- PL
- Poland
- Prior art keywords
- modulators
- odorant receptors
- odorant
- receptors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/02—Drug screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Otolaryngology (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58108704P | 2004-06-18 | 2004-06-18 | |
US58201104P | 2004-06-22 | 2004-06-22 | |
EP05792749A EP1771582A4 (en) | 2004-06-18 | 2005-06-20 | MODULATORS OF ODOR RECEIVERS |
US11/156,516 US7425445B2 (en) | 2004-06-18 | 2005-06-20 | Modulators that promote cell surface expression of odorant receptors |
EP08013482.8A EP2031063B1 (en) | 2004-06-18 | 2005-06-20 | Modulators of odorant receptors |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2031063T3 true PL2031063T3 (pl) | 2014-04-30 |
Family
ID=36034502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL08013482T PL2031063T3 (pl) | 2004-06-18 | 2005-06-20 | Modulatory receptorów węchowych |
Country Status (9)
Country | Link |
---|---|
US (6) | US7425445B2 (pl) |
EP (2) | EP2031063B1 (pl) |
JP (2) | JP5022217B2 (pl) |
CN (1) | CN101087879B (pl) |
AU (2) | AU2005258061C1 (pl) |
CA (1) | CA2571080C (pl) |
DK (1) | DK2031063T3 (pl) |
PL (1) | PL2031063T3 (pl) |
WO (1) | WO2006002161A2 (pl) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7811762B2 (en) * | 2006-03-30 | 2010-10-12 | Duke University | Identification of a novel gene underlying familial spastic paraplegia |
WO2008137993A1 (en) * | 2007-05-08 | 2008-11-13 | Duke University | Compositions and methods for characterizing and regulating olfactory sensation |
JP5690467B2 (ja) | 2008-04-11 | 2015-03-25 | 花王株式会社 | 嗅覚感度抑制剤のスクリーニング法 |
US9068226B2 (en) | 2009-12-04 | 2015-06-30 | Duke University | Compositions and methods for enhancing odorant receptor activity |
JP5520173B2 (ja) * | 2010-09-16 | 2014-06-11 | 花王株式会社 | ミューゲ香料素材の探索方法 |
WO2012056603A1 (ja) | 2010-10-25 | 2012-05-03 | パナソニック株式会社 | キメラ嗅覚受容体を用いてcAMPを産生する方法 |
CN103608674B (zh) * | 2011-04-14 | 2015-04-22 | 上海交通大学医学院 | 一种配位金属的气味化合物的探测方法 |
JP5921226B2 (ja) * | 2012-02-02 | 2016-05-24 | 花王株式会社 | ミューゲ香料素材の探索方法 |
US20130210775A1 (en) | 2012-02-09 | 2013-08-15 | Kao Corporation | Agent for inhibiting odor of pyrazine derivatives |
JP2015527074A (ja) * | 2012-09-10 | 2015-09-17 | ザ ジョンズ ホプキンズ ユニヴァーシティー | 細胞表面におけるタンパク質の発現及びシグナル伝達を増大するための組成物及び方法 |
JP2016523546A (ja) | 2013-06-29 | 2016-08-12 | フイルメニツヒ ソシエテ アノニムFirmenich Sa | 匂い物質および香り受容体を特定、単離および使用する方法 |
EP2832347B1 (en) | 2013-08-02 | 2018-01-31 | Takasago International Corporation | Method for identifying patchouli odorant materials |
US10041935B2 (en) | 2013-08-05 | 2018-08-07 | New York University | Identification of olfactory receptors sensitive to different odorants |
EP3084440B1 (en) * | 2013-12-16 | 2019-02-27 | Monell Chemical Senses Center | Methods of identifying modulators of olfactory receptors |
WO2015116771A1 (en) | 2014-01-29 | 2015-08-06 | The Johns Hopkins University | Compositions and methods for increasing the expression and signalling of proteins on cell surfaces |
ES2961258T3 (es) * | 2015-06-10 | 2024-03-11 | Firmenich & Cie | Líneas celulares para el cribado de receptores de aroma y olor |
WO2017024028A1 (en) * | 2015-08-03 | 2017-02-09 | Research Foundation Of The City University Of New York | Dna sequence that increases odorant receptor representation in the olfactory system |
CN109071626A (zh) | 2016-02-24 | 2018-12-21 | 阿罗姆斯公司 | 用于检测气味、香味和味道的生物传感器 |
CA3034419C (en) * | 2016-09-30 | 2023-01-03 | Mars, Incorporated | Screening methods using olfactory receptors and novel compounds identified using the same |
WO2018081588A1 (en) | 2016-10-27 | 2018-05-03 | Duke University | Methods for vapor detection and discrimination with mammalian odorant receptors expressed in heterologous cells |
US11255830B2 (en) | 2016-12-30 | 2022-02-22 | Research Foundation Of The City University Of New York | Biosensor exhibiting sensitivity to trinitrotoluene |
CN110494413B (zh) | 2017-01-30 | 2022-11-22 | 凯姆克姆公司 | 降低恶臭感知的化合物及其用途 |
JP7062636B2 (ja) * | 2017-03-07 | 2022-05-06 | 高砂香料工業株式会社 | マリンノートを呈する香料素材のスクリーニング方法 |
US10209239B1 (en) | 2017-08-16 | 2019-02-19 | Aromyx Corporation | Method of making an aromagraph comprising ectopic olfactory receptors |
WO2020006108A2 (en) * | 2018-06-26 | 2020-01-02 | Duke University | Synthetic odorant receptors |
US11813926B2 (en) | 2020-08-20 | 2023-11-14 | Denso International America, Inc. | Binding agent and olfaction sensor |
US11636870B2 (en) | 2020-08-20 | 2023-04-25 | Denso International America, Inc. | Smoking cessation systems and methods |
US11760170B2 (en) | 2020-08-20 | 2023-09-19 | Denso International America, Inc. | Olfaction sensor preservation systems and methods |
US11932080B2 (en) | 2020-08-20 | 2024-03-19 | Denso International America, Inc. | Diagnostic and recirculation control systems and methods |
US11760169B2 (en) | 2020-08-20 | 2023-09-19 | Denso International America, Inc. | Particulate control systems and methods for olfaction sensors |
US11881093B2 (en) | 2020-08-20 | 2024-01-23 | Denso International America, Inc. | Systems and methods for identifying smoking in vehicles |
US11828210B2 (en) | 2020-08-20 | 2023-11-28 | Denso International America, Inc. | Diagnostic systems and methods of vehicles using olfaction |
GB202108867D0 (en) | 2021-06-21 | 2021-08-04 | Givaudan Sa | Screening system |
CN116200456B (zh) * | 2023-04-27 | 2023-07-28 | 汉王科技股份有限公司 | 利用嗅觉受体检测食品变质的方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4861719A (en) | 1986-04-25 | 1989-08-29 | Fred Hutchinson Cancer Research Center | DNA constructs for retrovirus packaging cell lines |
AU3069189A (en) | 1988-02-05 | 1989-08-25 | Trustees Of Columbia University In The City Of New York, The | Retroviral packaging cell lines and processes of using same |
CA1339354C (en) | 1988-09-01 | 1997-08-26 | The Whitehead Institute For Biomedical Research | Recombinant retroviruses with amphotropic and ecotropic host ranges |
GB8901778D0 (en) | 1989-01-27 | 1989-03-15 | Univ Court Of The University O | Manipulatory technique |
SK282843B6 (sk) | 1993-07-13 | 2002-12-03 | Rhone-Poulenc Rorer S. A. | Defektný rekombinantný adenovírus a farmaceutický prostriedok s jeho obsahom |
FR2715847B1 (fr) | 1994-02-08 | 1996-04-12 | Rhone Poulenc Rorer Sa | Composition contenant des acides nucléiques, préparation et utilisations. |
FR2730637B1 (fr) | 1995-02-17 | 1997-03-28 | Rhone Poulenc Rorer Sa | Composition pharmaceutique contenant des acides nucleiques, et ses utilisations |
US5993778A (en) * | 1997-05-07 | 1999-11-30 | Firestein; Stuart J. | Functional expression of, and assay for, functional cellular receptors in vivo |
AU2001229360A1 (en) * | 2000-01-14 | 2001-07-24 | The Johns-Hopkins University | Isolation and in vitro differentiation of conditionally immortalized murine olfactory receptor neurons |
US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
WO2003025130A2 (en) * | 2001-09-14 | 2003-03-27 | Incyte Genomics, Inc. | Receptors and membrane-associated proteins |
WO2003098221A1 (en) * | 2002-05-02 | 2003-11-27 | Evotec Neurosciences Gmbh | Diagnostic and therapeutic use of ensadin-0255 gene and protein for neurodegenerative diseases |
AU2003230273A1 (en) * | 2002-05-07 | 2003-11-11 | Immunex Corporation | Cytokine polypeptides |
EP1556490A4 (en) * | 2002-10-22 | 2006-04-05 | Nuvelo Inc | NEW NUCLEIC ACIDS AND POLYPEPTIDES |
-
2005
- 2005-06-20 CA CA2571080A patent/CA2571080C/en active Active
- 2005-06-20 PL PL08013482T patent/PL2031063T3/pl unknown
- 2005-06-20 US US11/156,516 patent/US7425445B2/en active Active
- 2005-06-20 CN CN2005800275380A patent/CN101087879B/zh active Active
- 2005-06-20 EP EP08013482.8A patent/EP2031063B1/en active Active
- 2005-06-20 JP JP2007516837A patent/JP5022217B2/ja active Active
- 2005-06-20 EP EP05792749A patent/EP1771582A4/en not_active Withdrawn
- 2005-06-20 WO PCT/US2005/021921 patent/WO2006002161A2/en active Application Filing
- 2005-06-20 AU AU2005258061A patent/AU2005258061C1/en active Active
- 2005-06-20 DK DK08013482.8T patent/DK2031063T3/da active
-
2007
- 2007-06-08 US US11/811,050 patent/US7691592B2/en active Active
-
2008
- 2008-09-09 US US12/207,102 patent/US7879565B2/en active Active
- 2008-10-30 US US12/261,778 patent/US20090124003A1/en not_active Abandoned
- 2008-10-30 US US12/261,774 patent/US7838288B2/en active Active
-
2009
- 2009-10-16 AU AU2009227827A patent/AU2009227827A1/en not_active Ceased
-
2010
- 2010-04-26 US US12/767,294 patent/US20100222561A1/en not_active Abandoned
-
2012
- 2012-01-26 JP JP2012014665A patent/JP5340430B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
EP2031063A3 (en) | 2009-03-11 |
CA2571080C (en) | 2013-05-28 |
US20090123997A1 (en) | 2009-05-14 |
AU2005258061A1 (en) | 2006-01-05 |
CN101087879B (zh) | 2013-08-14 |
EP1771582A2 (en) | 2007-04-11 |
US20090092997A1 (en) | 2009-04-09 |
US7838288B2 (en) | 2010-11-23 |
US20080124742A1 (en) | 2008-05-29 |
JP2008503220A (ja) | 2008-02-07 |
EP1771582A4 (en) | 2008-04-16 |
JP5340430B2 (ja) | 2013-11-13 |
US20090124003A1 (en) | 2009-05-14 |
US7691592B2 (en) | 2010-04-06 |
AU2005258061B2 (en) | 2009-07-16 |
AU2005258061B9 (en) | 2009-12-17 |
US7879565B2 (en) | 2011-02-01 |
US20100222561A1 (en) | 2010-09-02 |
AU2009227827A2 (en) | 2010-03-11 |
AU2005258061C1 (en) | 2010-09-09 |
WO2006002161A2 (en) | 2006-01-05 |
US7425445B2 (en) | 2008-09-16 |
JP2012105660A (ja) | 2012-06-07 |
CN101087879A (zh) | 2007-12-12 |
JP5022217B2 (ja) | 2012-09-12 |
EP2031063A2 (en) | 2009-03-04 |
US20060057640A1 (en) | 2006-03-16 |
WO2006002161A3 (en) | 2007-06-21 |
AU2009227827A1 (en) | 2009-11-05 |
EP2031063B1 (en) | 2013-11-06 |
DK2031063T3 (da) | 2014-01-27 |
CA2571080A1 (en) | 2006-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1771582A4 (en) | MODULATORS OF ODOR RECEIVERS | |
EP1773337A4 (en) | MODULATORS OF NUCLEAR RECEPTORS | |
TWI366458B (en) | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors | |
IL179526A0 (en) | Modulators of muscarinic receptors | |
IL179910A0 (en) | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors | |
ZA200806028B (en) | Modulators of muscarinic receptors | |
IL181388A0 (en) | Modulators of muscarinic receptors | |
GB0420719D0 (en) | Novel allosteric modulators | |
GB0420722D0 (en) | Novel allosteric modulators | |
AP2552A (en) | P-cadherin antibodies | |
ZA200803452B (en) | Modulation of glucocorticoid receptor expression | |
GB0400440D0 (en) | Receptor modulators | |
ZA200609013B (en) | 3-(4-heteroarylcyclohexylamino) cyclopentanecarbox-amides as modulators of chemokine receptors | |
IL176215A0 (en) | Modulators of muscarinic receptors | |
IL198989A0 (en) | Modulators of cb1 receptors | |
IL191602A0 (en) | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors | |
EP1751115A4 (en) | THERAMUTEINMODULATOREN | |
EP1806147A4 (en) | USE OF IMMUNOSUPPRESSIVE RECEPTOR | |
ZA200705116B (en) | Modulators of muscarinic receptors | |
EP1807388A4 (en) | ACYCLIC HYDRAZINE ALSCANO BINOID RECEPTOR MODULATORS | |
GB0403889D0 (en) | Uses of er-beta modulators | |
ZA200606687B (en) | Oxydecahydronaphthalene modulators of HM74 | |
HK1116217A1 (en) | Modulators of odorant receptors | |
ZA200804438B (en) | 3-Aminocyclopentanecarboxamides as modulators of chemokine receptors | |
GB0507793D0 (en) | Allosteric modulators of glutamate receptors |